UPDATE 2-Roche's Tecentriq notches third cancer cocktail trial win
March 20, 2018 at 05:48 AM EDT
* Still awaiting overall survival data (Recasts to focus on Roche's strategy, adds analyst comment)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|